EDAP TMS S.A. (EDAP)
NASDAQ: EDAP · Real-Time Price · USD
3.645
-0.125 (-3.32%)
At close: Mar 27, 2026, 4:00 PM EDT
3.730
+0.085 (2.33%)
After-hours: Mar 27, 2026, 4:04 PM EDT
EDAP TMS Revenue
In the year 2025, EDAP TMS had annual revenue of 62.42M EUR, down -2.65%. EDAP TMS had revenue of 18.94M in the quarter ending December 31, 2025, a decrease of -6.80%.
Revenue (ttm)
62.42M EUR
Revenue Growth
-2.65%
P/S Ratio
1.91
Revenue / Employee
201,342 EUR
Employees
310
Market Cap
136.62M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 62.42M | -1.70M | -2.65% |
| Dec 31, 2024 | 64.12M | 3.69M | 6.11% |
| Dec 31, 2023 | 60.42M | 5.31M | 9.64% |
| Dec 31, 2022 | 55.11M | 11.04M | 25.06% |
| Dec 31, 2021 | 44.07M | 2.40M | 5.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| McKesson | 397.96B |
| Cencora | 325.78B |
| Cardinal Health | 244.67B |
| Henry Schein | 13.18B |
| Accendra Health | 2.76B |
| 111, Inc. | 1.91B |
| Cosmos Health | 59.79M |
| Synergy CHC | 34.59M |
EDAP News
- 2 days ago - EDAP TMS S.A. (EDAP) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue - GlobeNewsWire
- 17 days ago - EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference - GlobeNewsWire
- 23 days ago - EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026 - GlobeNewsWire
- 6 weeks ago - EDAP Announces Appointment of David Horn to Board of Directors - GlobeNewsWire
- 2 months ago - EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance - GlobeNewsWire
- 4 months ago - EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU - GlobeNewsWire
- 4 months ago - EDAP to Present at Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire